KOREAN DRUG (014570) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, KOREAN DRUG (014570) reported revenue of 62.5 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202562.5 billion KRW6.9 billion KRW6.5 billion KRW[source]
202473.0 billion KRW9.1 billion KRW3.0 billion KRW[source]
202381.4 billion KRW18.0 billion KRW-4.9 billion KRW[source]
202280.0 billion KRW14.3 billion KRW11.8 billion KRW[source]
202174.5 billion KRW11.3 billion KRW9.0 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202594.3 billion KRW11.2 billion KRW83.1 billion KRW[source]
202488.9 billion KRW10.8 billion KRW78.1 billion KRW[source]
202389.7 billion KRW12.6 billion KRW77.1 billion KRW[source]
202294.5 billion KRW9.8 billion KRW84.7 billion KRW[source]
202188.6 billion KRW11.9 billion KRW76.7 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice